VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
1.270
-0.030 (-2.31%)
May 9, 2025, 10:54 AM - Market open
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $18.83 million as of May 9, 2025. Its market cap has decreased by -42.42% in one year.
Market Cap
18.83M
Enterprise Value
-30.93M
1-Year Change
-42.42%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $18.83M, a decrease of -91.80%. That is a compound annual growth rate of -38.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 19.28M | -60.99% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |